|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07D 239/48 | |
| C07D 405/12 | |||
| C07D 403/12 | |||
| C07D 401/12 | |||
| C07D 401/14 | |||
| A61K 31/506 | |||
| A61K 35/00 | |||
| A61P 37/00 | |||
| A61P 29/00 |
| (11) | Patento numeris | 1606265 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04719989.8 |
| Europos patento paraiškos padavimo data | 2004-03-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2005-12-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-02-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2004/002616 |
| Data | 2004-03-12 |
| (87) | Numeris | WO 2004/080980 |
| Data | 2004-09-23 |
| (30) | Numeris | Data | Šalis |
| 0305929 | 2003-03-14 | GB | |
| 0319227 | 2003-08-15 | GB | |
| 0322370 | 2003-09-24 | GB |
| (72) |
.GARCIA-ECHEVERRIA, Carlos, CH
KANAZAWA, Takanori, JP
KAWAHARA, Eiji, JP
MASUYA, Keiichi, JP
MATSUURA, Naoko, JP
MIYAKE, Takahiro, JP
OHMORI, Osamu, JP
UMEMURA, Ichiro, JP
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | 2, 4- DI (PHENYLAMINO) PYRIMIDINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS |
| 2, 4- DI (PHENYLAMINO) PYRIMIDINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS |